Journal
JOURNAL OF LUMINESCENCE
Volume 174, Issue -, Pages 77-84Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jlumin.2016.02.004
Keywords
SB202190; Human serum albumin; Drug-protein interaction; Fluorescence spectroscopy; Molecular docking
Categories
Funding
- High Impact Research Grant by the Ministry of Higher Education, Malaysia [UM.C/625/1/HIR/MoE/SC/02]
- University of Malaya [PG073/2013B]
Ask authors/readers for more resources
The interaction of SB202190, a p38 mitogen-activated protein kinase inhibitor with the main drug transporter in human circulation, human serum albumin (HSA) was studied using fluorescence spectroscopy and in silico docking methods. The association constant, K-a of the binding reaction was determined to be 3.24 +/- 0.07 x 10(4) M-1 at 25 degrees C based on fluorescence quenching titration results. The values of enthalpy change and entropy change for the interaction were found as -8.54 kJ mol(-1) and 58.01 J mol(-1) K-1, respectively. Both thermodynamic data and docking results suggested the involvement of hydrophobic and van der Waals forces in the complex formation. Three-dimensional fluorescence data of SB202190-HSA complex demonstrated significant changes in the microenvironment around the protein fluorophores upon drug binding. Comparison of HSA thermograms obtained in the absence and the presence of SB202190 suggested improved protein thermal stability upon complexation with the drug. Competitive drug displacement results as well as modeling data concluded the preferred binding site of SB202190 on HSA as Sudlow's site I. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available